Two FTSE 100 dividend stocks I’d buy NOW

Plenty of FTSE 100 companies are offering very generous dividend yields at the moment. Here’s a look at two dividend stocks Edward Sheldon would buy now.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

As we begin November, stock market volatility is elevated. It’s not hard to see why. Covid-19, the US election, Brexit… there’s a lot of uncertainty right now.

Personally, I think this uncertainty is creating some fantastic buying opportunities for long-term investors, particularly in the dividend stock area. At present, plenty of well-established FTSE 100 companies are offering very generous yields. Here’s a look at two such dividend stocks I’d buy now.

A FTSE 100 dividend stock with a 5% yield

One FTSE 100 dividend stock I believe looks attractive at the moment is BAE Systems (LSE: BA). Its share price has been hammered recently. A month ago, it was near 500p. In the last week however, it has dipped below 400p.

There are a few reasons BAE’s share price has tanked over the last month. One is that investors are concerned that a Joe Biden US election win could result in lower US defence spending. Another is that there’s concern that government spending on Covid-19 will reduce the funds available to defence departments.

Both concerns are valid. However, I see the share price pullback as excessive. While Biden may not be as keen on defence as Trump, he’s made it clear that, if elected, he’ll push for continued military modernisation, including efforts to upgrade technology, strengthen cybersecurity, and develop drones and other autonomous vehicles.

And I don’t think defence spending in other countries is going to fall off a cliff. Given the high level of geopolitical tension worldwide, governments can’t afford to completely ignore defence.

It’s worth pointing out that only a few months ago, BAE’s chairman bought a ton of shares in the company at around the 480p mark. This suggests he thought there was value at that price. Today, the shares are much cheaper.

BAE is forecast to pay about 23p per share in dividends for this year. At the current share price, that equates to a yield of about 5.2%. The FTSE 100 stock’s forward-looking P/E ratio is about 10. All things considered, I see a lot of value here.

A dividend yield that’s hard to ignore

Another FTSE 100 dividend stock I’d snap up now is pharmaceutical giant GlaxoSmithKline (LSE: GSK). Like BAE, it’s underperformed recently. Over the last three months, its share price has fallen by about 10%. I think this share price weakness has created a great buying opportunity for dividend investors.

Glaxo’s third-quarter results, issued on 28 October, weren’t brilliant. For the period, turnover was down 3% at constant exchange rates while adjusted earnings per share were up just 1%. However, I’m convinced the long-term story here remains attractive.

In the long run, the company should benefit from both the world’s ageing population and increased healthcare spending in emerging economies. Meanwhile, by splitting up its business into two separate companies, it should create value for shareholders.

GSK is forecast to pay out 80p per share to investors this year. At the current share price, that equates to a dividend yield of 5.7%. In today’s low-interest-rate environment, I think that’s hard to ignore. The stock’s forward-looking P/E ratio is a very undemanding 11.7. Putting this all together, I see this FTSE 100 dividend stock as a buy right now.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Edward Sheldon owns shares in BAE Systems and GlaxoSmithKline. The Motley Fool UK has recommended GlaxoSmithKline. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Recently released: October’s small-cap stock recommendation [PREMIUM PICKS]

We believe the UK small-cap market offers a myriad of opportunities across a wide range of different businesses and industries.

Read more »

Investing Articles

Here’s how a Stocks and Shares ISA and Lifetime ISA could supercharge my wealth!

Individual Savings Accounts (ISAs) can help UK share investors take their earnings to the next level. And their importance is…

Read more »

A person holding onto a fan of twenty pound notes
Investing Articles

A high-yield dividend ETF and an investment trust to consider this November!

Investors wanting to boost their passive income could benefit from investigating these high-yield funds and trusts, says Royston Wild.

Read more »

Investing Articles

2 of my favourite, cheap FTSE 100 growth shares this November!

These FTSE 100 growth shares could be great long-term picks to consider, reckons Royston Wild. At current prices he thinks…

Read more »

Investing Articles

Up 26%, can the BT share price really push higher still?

The BT share price has surged on several catalysts in 2024, but there’s evidence to suggest that the stock could…

Read more »

Man writing 'now' having crossed out 'later', 'tomorrow' and 'next week'
Investing Articles

What are the best dividend shares to buy right now?

As shares in B&M European Value Retail have fallen, the dividend yield has reached a 10-year high. Should investors be…

Read more »

Surprised Black girl holding teddy bear toy on Christmas
Investing Articles

My favourite FTSE 100 passive income stock that keeps the Christmas coffers full

The holiday season is expensive and can leave many consumers struggling to make ends meet. Here’s how I use a…

Read more »

Investing Articles

The latest growth forecasts suggest the Glencore share price will hit 555p!

Harvey Jones has been disappointed by the performance of the Glencore share price since he bought the commodity stock last…

Read more »